Covaxin update: Here’s how Bharat Biotech secured nod for India’s first indigenous Covid-19 vaccine
Covaxin news, update: On January 3, the Ministry of Health and Family Welfare announced that Emergency Use Authorization (EUA) has been granted to Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin. With approvals of two Covid-19 vaccines—Covaxin (Bharat Biotech) and Covishield (Serum Institute-Oxford), India is all set to begin one of the world’s biggest … Read more